参考文献/References:
[1] Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: a clinical review [J]. JAMA, 2013, 310(17): 1842-1850.
[2] Wick W, Osswald M, Wick A, et al. Treatment of glioblasto-ma in adults [J]. Ther Adv Neurol Disord, 2018, 11: 1277012020.
[3] Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblas-toma [J]. N Engl J Med, 2005, 352(10): 987-996.
[4] Zwirner K, Paulsen F, Schittenhelm J, et al. Prognostic pa-rameters and outcome after re-irradiation for progressive glioblastoma [J]. Acta Neurol Scand, 2017, 136(3): 239-245.
[5] Hammond SM. An overview of microRNAs [J]. Adv Drug Deliv Rev, 2015, 87: 3-14.
[6] Vishnoi A, Rani S. MiRNA biogenesis and regulation of diseases: an overview [J]. Methods Mol Biol, 2017, 1509: 1-10.
[7] Saliminejad K, Khorram KH, Soleymani FS, et al. An over-view of microRNAs: biology, functions, therapeutics, and analysis methods [J]. J Cell Physiol, 2019, 234(5): 5451-5465.
[8] Zhu X, Zhao Y, Hou W, et al. MiR-153 regulates cardio-myocyte apoptosis by targeting Nrf2/HO-1 signaling [J]. Chromosome Res, 2019, 27(3): 167-178.
[9] Huang Q, Xia J, Wang L, et al. miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy [J]. J Hematol Oncol, 2018, 11(1): 58.
[10] Bi CW, Zhang GY, Bai Y, et al. Increased expression of miR-153 predicts poor prognosis for patients with prostate cancer [J]. Medicine (Baltimore), 2019, 98(36): e16705.
[11] Olmez I, Love S, Xiao A, et al. Targeting the mesenchymal subtype in glioblastoma and other cancers via inhibition of diacylglycerol kinase alpha [J]. Neuro Oncol, 2018, 20(2): 192-202.
[12] Bhat K, Balasubramaniyan V, Vaillant B, et al. Mesenchy-mal differentiation mediated by NF-kappaB promotes radiation resistance in glioblastoma [J]. Cancer Cell, 2013, 24(3): 331-346.
[13] Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells [J]. Cancer Res, 2005, 65(14): 6029-6033.
[14] Kefas B, Godlewski J, Comeau L, et al. microRNA-7 inhi-bits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma [J]. Cancer Res, 2008, 68(10): 3566-3572.
[15] Lu SQ, Qiu Y, Dai WJ, et al. FOXR2 promotes the prolife-ration, invasion, and epithelial-mesenchymal transition in human colorectal cancer cells [J]. Oncol Res, 2017, 25(5): 681-689.
[16] Liu X, Liu N, Yue C, et al. FoxR2 promotes glioma prolife-ration by suppression of the p27 pathway [J]. Oncotarget, 2017, 8(34): 56255-56266.
[17] Deng X, Hou C, Liang Z, et al. MiR-202 suppresses cell proliferation by targeting foxr2 in endometrial adenocarci-noma [J]. Dis Markers, 2017, 2017: 2827435.
[18] Menzl I, Witalisz-Siepracka A, Sexl V. CDK8-novel thera-peutic opportunities [J]. Pharmaceuticals (Basel), 2019, 12\(2): .
[19] Greifenberg AK, Honig D, Pilarova K, et al. Structural and functional analysis of the Cdk13/Cyclin K complex [J]. Cell Rep, 2016, 14(2): 320-331.
[20] Liang J, Chen M, Hughes D, et al. CDK8 Selectively pro-motes the growth of colon cancer metastases in the liver by regulating gene expression of TIMP3 and matrix metallo-proteinases [J]. Cancer Res, 2018, 78(23): 6594-6606.
[21] Quereda V, Bayle S, Vena F, et al. Therapeutic targeting of CDK12/CDK13 in triple-negative breast cancer [J]. Cancer Cell, 2019, 36(5): 545-558.
相似文献/References:
[1]谢宝树 张 林 王 宇 贾 锋 殷玉华.复发性多发胶质母细胞瘤的预后分析[J].中国临床神经外科杂志,2016,(06):333.[doi:10.13798/j.issn.1009-153X.2016.06.005]
XIE Bao-shu,ZHANG Lin,WANG Yu,et al.Analysis of prognoses in patients with recurrent multiple glioblastomas[J].,2016,(11):333.[doi:10.13798/j.issn.1009-153X.2016.06.005]
[2]宋贵东 综述 高之宪 审校.贝伐单抗治疗复发胶质母细胞瘤的研究进展[J].中国临床神经外科杂志,2015,(10):638.[doi:10.13798/j.issn.1009-153X.2015.10.022]
[3]李继强 杨吉安 邵灵敏 吴庭枫 刘宝辉 陈谦学.稳定低表达BAG3的胶质母细胞瘤U87细胞株的构建及鉴定[J].中国临床神经外科杂志,2015,(06):353.[doi:10.13798/j.issn.1009-153X.2015.06.011]
LI Ji-qiang,YANG Ji-an,SHAO Ling-min,et al.Construction and identification of U87 glioblastoma cell strain with a stable low expression of BAG3[J].,2015,(11):353.[doi:10.13798/j.issn.1009-153X.2015.06.011]
[4]桂志勇 冯 军 黄俊红 白敬洋.靶向沉默c-fos基因表达对胶质瘤U87MG细胞增殖与侵袭的影响[J].中国临床神经外科杂志,2017,(12):834.[doi:10.13798/j.issn.1009-153X.2017.12.011]
GUI Zhi-yong,FENG Jun,HUANG Jun-hong,et al.Effects of c-fos targeted silence on proliferation and invasiveness of human glioma cell U87[J].,2017,(11):834.[doi:10.13798/j.issn.1009-153X.2017.12.011]
[5]王娇燕 孟凡华 刘魏然 魏春晓 林丽萍.SWI在胶质母细胞瘤与单发脑转移瘤鉴别中的价值[J].中国临床神经外科杂志,2018,(01):13.[doi:10.13798/j.issn.1009-153X.2018.01.005]
WANG Jiao-yan,MENG Fan-hua,LIU Wei-ran,et al.Value of susceptibility-weighted imaging in differentiative diagnosis of glioblastomas and solitary brain metastases[J].,2018,(11):13.[doi:10.13798/j.issn.1009-153X.2018.01.005]
[6]张治元 王汉东 樊友武 贾 玥 吴晋蓉.胶质肉瘤15例分析及文献复习[J].中国临床神经外科杂志,2018,(02):69.
ZHANG Zhi-yuan,WANG Han-dong,FAN You-wu,et al.Diagnosis and treatment of gliosarcoma: a report of 15 cases and literature review[J].,2018,(11):69.
[7]郑锐哲 姜秀峰 陈二涛 孙兆良 冯东福.胶质母细胞瘤卒中术后继发硬膜下水瘤1例[J].中国临床神经外科杂志,2019,(02):128.[doi:10.13798/j.issn.1009-153X.2019.02.022]
[8]胡 玥,薛小燕,李子超,等.阿苯达唑抑制胶质瘤裸鼠模型肿瘤生长[J].中国临床神经外科杂志,2019,(06):348.[doi:10.13798/j.issn.1009-153X.2019.06.010]
HU Yue,XUE Xiao-yan,LI Zi-chao,et al.Albendazole inhibits tumor growth in nude mice model of glioma[J].,2019,(11):348.[doi:10.13798/j.issn.1009-153X.2019.06.010]
[9]殷安安 陆 南 贺亚龙 章 翔 刘玉河.TRIM38基因非CpG岛DNA甲基化与胶质母细胞瘤临床预后的关系[J].中国临床神经外科杂志,2020,(02):76.[doi:10.13798/j.issn.1009-153X.2020.02.005]
YIN An-an,LU Nan,HE Ya-long,et al.Impacts of TRIM38 non-CpG island DNA methylation alterations on clinical prognosis in patients with glioblastomas[J].,2020,(11):76.[doi:10.13798/j.issn.1009-153X.2020.02.005]
[10]吴 蛟 易 勇 赵卓琳 周良学 周世军.贝伐珠单抗联合化疗治疗胶质母细胞瘤的meta分析[J].中国临床神经外科杂志,2020,(02):82.[doi:10.13798/j.issn.1009-153X.2020.02.007]
WU Jiao,YI Yong,ZHAO Zhuo-lin,et al.Efficacy and safety of bevacizumab combined with chemotherapy for glioblastoma: a meta-analysis[J].,2020,(11):82.[doi:10.13798/j.issn.1009-153X.2020.02.007]
[11]兰展仇洪冯磊黄章峰禤义张传东盘丽华.人脑胶质母细胞瘤miR-4516表达与病人预后的关系[J].中国临床神经外科杂志,2022,27(02):107.[doi:10.13798/j.issn.1009-153X.2022.02.012]
LAN Zhan,QIU Hong,FENG Lei,et al.Relationship between expression of miR-4516 in human glioblastoma tissues and patients’ prognoses[J].,2022,27(11):107.[doi:10.13798/j.issn.1009-153X.2022.02.012]